INTRODUCTION
Peroxisomes are ubiquitous organelles. Peroxisomal proteins are encoded by nuclear genes and are synthesized on cytosolic polysomes before being imported into peroxisomes posttranslationally [1] . So far, three peroxisomal targeting signals (PTSs) have been identified (reviewed in [2, 3] ). PTS1, the most common signal, is a conserved C-terminal tripeptide with the sequence SKL (one-letter amino acid codes) or conserved variants thereof. PTS2, a much less common signal, is a degenerate nonapeptide found at or near the N-terminus of a few proteins and is sometimes part of a cleaved presequence. The mPTS is a less well characterized hydrophilic motif found on some peroxisomal integral membrane proteins. Some peroxisomal proteins do not contain any of the PTSs so far identified and the mechanism(s) of their targeting are unknown.
Factors that recognize PTS1 or PTS2 have been identified in several species. PTS1 receptors are encoded by the PEX5 gene family [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . These peroxins (proteins involved in peroxisome assembly) are characterized by a tetratricopeptide repeat (TPR) domain in the C-terminal half of the protein. TPR domains consist of tandem arrays of a degenerate 34-residue motif. These domains are found in proteins with many diverse roles and have been implicated in protein-protein interactions [18] . Pex5 proteins have been localized to different subcellular compartments, i.e. primarily cytosolic [5, 10, 11, 17, 19] , associated with the outer side of the peroxisomal membrane [4, 9, 20] , in the peroxisomal matrix [12] and in both the cytosol and peroxisomes [8] . The PEX7 gene family encodes the PTS2 receptor [21] [22] [23] [24] [25] [26] [27] . Whether Pex7p is primarily cytosolic [21, 23, 26, 28] or primarily peroxisomal [22, 29] is also unclear. A shuttling model of PTS receptor function has been proposed to explain the different localizations reported for these peroxins [30] . Although Pex5p-and Pex7p-dependent targeting are independent processes in lower eukaryotes, both PTS receptors associate with a common Abbreviations used : GST, glutathione S-transferase ; MBP, maltose-binding protein ; ORF, open reading frame ; PTS, peroxisomal targeting signal ; TPR, tetratricopeptide repeat. 1 To whom correspondence should be addressed (e-mail rick.rachubinski!ualberta.ca).
Wild-type YlPex5p translated in itro recognized functional PTS1s specifically. This activity is abrogated by the substitution of an aspartic residue for a conserved glycine residue in the TPR domain (G455D) of YlPex5p encoded by the pex5-1 allele. Deletion analysis demonstrated that an intact TPR domain of YlPex5p is necessary but not sufficient for both interaction with a PTS1 and functional complementation of a strain lacking YlPex5p.
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network of docking factors including Pex13p, Pex14p and Pex17p at the peroxisomal membrane [19, [31] [32] [33] [34] [35] [36] [37] . Mammalian Pex5p and Pex7p have recently been reported to interact with Pex14p [38] [39] [40] [41] . Loss of function of either PTS receptor leads to disease states in humans, causing neonatal adrenoleucodystrophy and Zellweger syndrome in Pex5p mutation [11] and rhizomelic chondrodysplasia punctata in Pex7p deficiency [23] [24] [25] . Interestingly, import of proteins by the PTS1 and PTS2 pathways is not entirely independent in mammalian cells. The human [9] [10] [11] 42] , mouse [42] and Chinese hamster [15] PEX5 genes each encode two forms of the protein that differ by the presence or absence of a 37-residue insertion N-terminal to the TPR domain. The short form of Pex5p can functionally complement the PTS1 import defect in pex5 mutant cells but only the long form of the protein can also rescue the PTS2 import defect that is an additional feature of some pex5 cells [15, 42] .
The Yarrowia lipolytica pex5-1 (formerly pay32-1) mutant strain was identified as part of a genetic screen for mutants of peroxisome biogenesis [12] . Y. lipolytica strains in which Pex5p is mutated, or from which it is absent, have morphologically abnormal peroxisomes and fail to import a subset of peroxisomal matrix proteins, including those that are immunoreactive with anti-SKL antiserum. Most soluble proteins destined for peroxisomes are mislocalized to the cytosol or are found trapped in the peroxisomal membrane at an intermediate stage of import. For example, a 62 kDa anti-SKL-reactive protein was found stuck in the membrane with its immunoreactive portion in the peroxisomal matrix. In contrast, the import of thiolase (a PTS2-containing protein) into the peroxisomal matrix is normal in pex5 mutants and none of this protein is trapped at the membrane. The Y. lipolytica PEX5 gene encodes a 598-residue protein, YlPex5p, with high amino acid sequence similarity to PTS1 receptors from other species, especially in the TPR domain. In wild-type cells, YlPex5p is localized primarily to the inner side of the peroxisomal membrane but approx. 30 % of the protein is found in the peroxisomal matrix. Of the matrix pool of YlPex5p, most is complexed with anti-SKL-reactive proteins. The pex5-1 mutant produces an apparently full-length YlPex5p that is imported into peroxisomes but does not associate with the membrane and therefore does not complex with anti-SKLreactive proteins. YlPex5p has been proposed to be an intraorganellar component of the peroxisomal matrix translocation machinery [12] .
In the present study we present evidence that YlPex5p can specifically, directly and autonomously recognize PTS1 sequences. We report on the nature of the pex5-1 mutation and its effect on PTS1 binding. A detailed deletion analysis reveals that the TPR domain of YlPex5p is necessary but not sufficient for PTS1 binding or for functional complementation of a strain lacking YlPex5p.
MATERIALS AND METHODS

Strains and media
The yeast strains used in this study are listed in Table 1 . Yeast cells were grown at 30 mC in complete (YEPD) or minimal (YNA, YNO, 2iCMD, 2iCMO) medium, as required. YEPD and YNO have been described [12] . YNA contained 0.67 % yeast nitrogen base without amino acids (Difco, Detroit, MI, U.S.A.) plus 2 % (w\v) sodium acetate. YNA and YNO were supplemented with leucine, uracil and lysine, each at 50 µg\ml, as required. 2iCMD contained 1.34 % (w\v) yeast nitrogen base without amino acids, complete supplement mixture (minus leucine and uracil, as appropriate) at twice the concentration recommended by the manufacturer (BIO 101, Vista, CA, U.S.A.) plus 2 % (w\v) glucose. 2iCMO contained 1.34 % yeast nitrogen base without amino acids, complete supplement mixture (minus leucine and uracil, as appropriate) at twice the recommended concentration, plus 0.05 % (v\v) Tween 40 and 0.1 % (v\v) oleic acid.
Sequencing the pex5-1 allele and creation of the pex5-G455D strain
Genomic DNA isolated from Y. lipolytica wild-type and pex5-1 strains was used as a template for PCR with primers 32RI5h and 32RI3h (Table 2) . PCR products were made blunt with the Klenow fragment of DNA polymerase I (Klenow) and cloned into the SmaI site of pGEM7Zf(j) (Promega, Madison, WI, U.S.A.).
Site-directed mutagenesis of the PEX5 gene was used to direct a Gly Asp substitution at codon 455. A HindIII fragment of Y. lipolytica genomic DNA including the entire PEX5 gene [12] was Table 1 Yeast strains used in this study Strain E122 was provided by C. Gaillardin (Thiverval-Grignon, France) ; strains E : GDU3 and pex5-G455D were from the present study. 
Strain
ligated into plasmid pRS425 [43] Ura + colonies were screened to test for site-specific integration of the plasmid and maintenance of the desired mutation. Strain E :GDU3, which contains one wild-type and one mutant copy of the PEX5 gene flanking the URA3 gene (Table 1) , was grown in YEPD to relax uracil selection. Cells were plated on YNA containing 0.075 % 5-fluoro-orotic acid to select against cells with a functional URA3 gene. Colonies resistant to 5-fluoroorotic acid were screened to find a strain, pex5-G455D (Table 1) , that had lost the URA3 marker by homologous recombination between the PEX5 genes and had retained the mutant allele.
Generation of plasmids encoding YlPex5p and variants
The pKK series of plasmids was prepared in pBluescriptSKII(k) for the synthesis of YlPex5p and variants in itro. Single-stranded DNA from p425PEX5 was used as a template for site-directed mutagenesis with oligonucleotide KK (Table 2) to create a consensus site for mammalian translational initiation [45] and a KpnI site upstream of the initiation codon of the PEX5 gene. The resulting plasmid, p425KKII, was digested with KpnI and ClaI to yield an insert that was ligated into pBluescriptSKII(k) to make plasmid pBSKK. A SphI fragment from p425PEX5 or pGD∆X (consisting of nt 139-1873 of the wild-type PEX5 or mutant pex5-G455D genes respectively) was exchanged against the equivalent region of pBSKK to generate plasmids pKKWT and pKKGD respectively.
Genes encoding truncated variants of YlPex5p were created by PCR, with the genomic clone of PEX5 as template. To create Nterminal truncations, oligonucleotide KKBT, KKCT or KKET (Table 2 ) was used as the upstream primer ; oligonucleotide KKREV (Table 2 ) was used as the downstream primer. PCR products were ligated into the EcoRV site of pGEM5Zf(j) (Promega) to make plasmids pG5BT, pG5CT and pG5ET respectively. A 268 bp KpnI-EcoRV fragment of pG5BT, a 57 bp KpnI-SalI fragment of pG5CT and a 281 bp KpnI-XhoI fragment of pG5ET were exchanged against the equivalent regions of pKKWT to generate plasmids pKKBT, pKKCT and pKKET respectively. To make C-terminal truncations of YlPex5p, oligonucleotide 32RI5h was used as the upstream primer and oligonucleotide BIAT, BIDT or BIFT (Table 2 ) was used as the downstream primer, thereby creating a termination codon in the PEX5 gene followed by a SnaBI site. PCR products were digested with ApaI and SnaBI and ligated into pRcCMV (Invitrogen, Carlsbad, CA, U.S.A.) to give plasmids pRcA, pRcD and pRcF respectively. A 189 bp EcoRV-SnaBI fragment of pRcA was ligated into pKKWT digested completely with StuI and partly with EcoRV to give plasmid pKKAT. A 66 bp NdeI-SnaBI fragment of pRcD was ligated into pKKWT digested with NdeI and StuI to give plasmid pKKDT. A 128 bp XhoI-SnaBI fragment of pRcF was ligated into pKKWT digested with XhoI-StuI to give plasmid pKKFT. Plasmid pKKBF was created by exchanging the KpnI-XhoI fragment of pKKFT for the equivalent region of pKKBT. Plasmid pKKCF was created by exchanging the KpnI-NdeI fragment of pKKFT with the equivalent region of pKKCT.
The PEX5 promoter was used to drive the expression in i o of genes encoding truncated YlPex5p variants. The HindIII fragment of p425KKII was ligated into pBluescriptSKII(k) such that the direction of transcription of the PEX5 gene was opposite that of the LacZ gene. This created plasmid pBSHK containing approx. 1 kbp of Y. lipolytica genomic DNA 5h to the initiation codon of PEX5 located between KpnI sites. The KpnI fragment of pBSHK was ligated into the KpnI sites (in the correct orientation with respect to the ORFs) of the appropriate pKK plasmid to give plasmids pKPAT, pKPDT, pKPFT, pKPBT, pKPCT, pKPET and pKPBF respectively. The promoter-ORF combinations were liberated from the pKP plasmids with HindIII and ligated into the E. coli\Y. lipolytica shuttle vector pINA443 (ARS68, URA3 ; a gift from C. Gaillardin, Thiverval-Grignon, France) to give plasmids p443AT, p443DT, p443FT, p443BT, p443CT, p443ET and p443BF respectively. Expression of the wild-type PEX5 gene was from plasmid p443KK, consisting of the HindIII fragment of plasmid p425KKII in pINA443. Plasmids were introduced into the pex5-KO strain by electroporation.
PTS1 binding assays in vitro
Variants of glutathione S-transferase (GST) modified at their Ctermini were encoded by a series of plasmids based on pGEXQ, a derivative of pGEX4T1 (Amersham-Pharmacia Biotech).
Complementary oligonucleotides EQ1 and EQ2 (Table 2) were ligated into pGEX4T1 digested with BamHI and EcoRI to yield plasmid pGEXQ, in which the EcoRI site of pGEX4T1was destroyed, thereby creating a codon for glutamine (CAA) in place of that for glutamic acid (GAA). Plasmids pGEXQ-SKL, pGEXQ-LKS, pGEXQ-AKI and pGEXQ-SKLS (encoding GST-SKL, GST-LKS, GST-AKI and GST-SKLS respectively) were made by ligating annealed oligonucleotide pairs SKL1 and SKL2, LKS1 and LKS2, AKI1 and AKI2, and SKLS1 and SKLS2 respectively (Table 2 ) into pGEXQ digested with SalI and NotI. The sequences of the C-termini of the encoded GST variants are LVPRGSPQFPGR(SKL\LKS\AKI\SKLS) respectively. The pGEXQ variants were transformed into protease-deficient E. coli BLR(DE3) cells (Novagen, Madison, WI, U.S.A.). Cells were disrupted by incubation with B-PER bacterial protein extraction reagent (Pierce, Rockford, IL, U.S.A.). Cell extracts were passed over glutathione-Sepharose to isolate GST proteins. Bound material was eluted with 10 mM reduced glutathione in 50 mM Tris\HCl, pH 8.0. Eluted proteins were dialysed at 4 mC for 4 h against P8BB binding buffer [20 mM HEPES\KOH (pH 7.3)\110 mM potassium acetate\ 5 mM sodium acetate\2 mM magnesium acetate\1 mM EDTA\ 2 mM dithiothreitol] [4] containing 20 % (v\v) glycerol, then stored at k80 mC until needed.
pMBP5 encodes MBP-PEX5, a recombinant protein consisting of all except the first 46 residues of YlPEX5p fused to the C-terminus of E. coli maltose-binding protein (MBP) [12] . pMBP5 and pMALc-2 (New England Biolabs, Mississauga, Ontario, Canada) were used to produce MBP-PEX5 and MBP respectively in E. coli BLR(DE3) cells. Cells were disrupted, and MPB-PEX5 and MBP were purified on amylose resin, then dialysed and stored as described above.
Glutathione-Sepharose beads were mixed with an equal volume of P8BB buffer containing 20 % (v\v) glycerol and GSTvariant protein chimaera at a concentration of 7.5 µg\µl at room temperature for 30 min to saturate GST-binding sites. After extensive washing with P8BB containing 10 % (v\v) glycerol, 20 µl of loaded beads was mixed with 200 µl of blocking buffer [P8BB containing 10 % (v\v) glycerol, 0.2 % (v\v) Nonidet P40 and BLR(DE3) cell extract at 10 µg\µl] to block non-specific protein-binding sites. MBP-PEX5 (5 µg) or an equimolar amount of MBP was mixed with 200 µl of blocking buffer, incubated on ice for 30 min and centrifuged at 16 000 g for 10 min. The supernatant was added to the bead mixture and incubated at room temperature for 90 min with gentle mixing. Beads were centrifuged at 500 g for 5 min, after which the supernatant was removed. Beads were then washed with 400 µl of each of (1) P8BB containing 10 % (v\v) glycerol, 0.2 % (v\v) Nonidet P40 and 2 µg\µl BSA, (2) P8BB containing 10 % (v\v) glycerol, 0.1 % (v\v) Nonidet P40 and 2 µg\µl BSA, and (3) P8BB containing 10 % (v\v) glycerol. Wash buffers were ice-cold ; centrifugations were performed at 4 mC. Washed beads were resuspended in 20 µl of SDS\PAGE sample buffer and boiled for 5 min. Eluted proteins were analysed by SDS\PAGE, followed by staining with Coomassie Blue. All blocking and wash buffers contained protease inhibitors [leupeptin, pepstatin and aprotinin (each at 1 µg\ml), 0.5 mM benzamidine hydrochloride, 5 mM NaF and 1 mM PMSF]. In some experiments (see the Results section), E. coli cell extract and BSA were omitted from the blocking buffer and wash buffers respectively.
Synthesis of YlPex5p variants in itro was performed with a coupled reticulocyte lysate system for transcription\translation in itro with T7 RNA polymerase. [$&S]Methionine incorporation into protein was assessed by precipitation with trichloroacetic acid. An aliquot of lysate corresponding to 50 000 precipitated radioactive counts of wild-type YlPex5p, or an aliquot containing the number of radioactive counts from an equimolar amount of a YlPex5p variant (unless specified otherwise), was brought to a final volume of 2 µl (unless specified otherwise) with unprogrammed reticulocyte lysate that had been diluted 1 : 1 with water. The diluted mixture was processed for binding as described above for MBP proteins, except that blocking buffer contained 10 µg\µl BSA instead of E. coli lysate. Proteins released from beads by being boiled in SDS\PAGE sample buffer were analysed by SDS\PAGE and fluorography. Dried gels were exposed to preflashed Kodak XAR-5 X-ray film at k80 mC.
Analytical procedures
Yeast lysates were prepared by disruption of cells with glass beads. Protein concentration was determined with a commercially available kit (Bio-Rad Laboratories, Mississauga, Ontario, Canada) with BSA as the standard. Immunoblotting was performed essentially as described [46] . Immunodetection was by enhanced chemiluminescence (Amersham-Pharmacia Biotech) with guinea-pig anti-YlPex5p primary antibodies [12] and secondary horseradish peroxidase-conjugated goat anti-(guineapig) IgG. Computer alignment of protein sequences was performed with the CLUSTAL program.
RESULTS
YlPex5p can specifically recognize a protein terminating in PTS1
We tested the ability of YlPex5p to recognize a PTS1 tripeptide by using a PTS1 binding assay in itro modelled on that of McCollum et al. [4] . GST variants ending in a PTS1 (GST-SKL) or the reverse tripeptide LKS (GST-LKS), which does not resemble a PTS1 but maintains its charge density, were immobilized on glutathione-Sepharose beads. MBP-PEX5, a chimaera consisting of YlPex5p lacking its first 46 residues fused to the C-terminus of MBP, was retained on GST-SKL beads but not on GST-LKS beads ( Figure 1A ). MBP alone was not retained on either GST-SKL or GST-LKS beads ( Figure 1A) . Therefore the MBP-PEX5 fusion protein had specific PTS1-binding activity located in its YlPex5p domain. The specificity of this interaction is further shown by the fact that MBP-PEX5 was enriched from a complex mixture of proteins, an E. coli lysate, by GST-SKL beads. Binding reactions were repeated with MBP-PEX5 and MBP in the absence of any additional protein during the incubation or washing steps ( Figure 1B ). MBP-PEX5 was still retained specifically on the GST-SKL beads, suggesting that the interaction between YlPex5p and PTS1 is direct and does not require other factors.
pex5-1 phenotype arises from the substitution of a conserved amino acid residue in the TPR domain of YlPex5p
The pex5-1 strain synthesizes an apparently full-length YlPex5p that is imported into peroxisomes but fails to associate with anti-SKL-reactive proteins [12] . The nature of the mutation in pex5-1 cells was determined by PCR amplification and sequencing of the PEX5 alleles from both pex5-1 and wild-type strains. A single change from the wild-type PEX5 gene was found in the pex5-1 allele. A G A transition at nt 1364 results in a Gly Asp substitution at residue 455 of YlPex5p (Figure 2A ). Gly-455 is located in the fifth TPR motif of YlPex5p ; its functional importance is highlighted by the fact that glycine is conserved at this position in all known Pex5p family members ( Figure 2B ).
To demonstrate further that the pex5-1 phenotype was due to the identified mutation, an allele of PEX5 encoding Pex5p-G455D, with an aspartic residue at position 455, was created by site-directed mutagenesis. The mutant allele was used to replace the wild-type gene in the E122 strain, generating the strain pex5-G455D ( Table 1 ). The pex5-G455D strain manifests the same growth defect on oleate medium as the original mutant pex5-1 and the PEX5 gene disruption strain, pex5-KO [12] (Figure 3) . These results confirm that the G455D substitution is sufficient to inactivate YlPex5p, thus preventing proper peroxisome assembly and function, including the utilization of fatty acids. Pex5p-G455D was synthesized at normal levels in the pex5-G455D strain (results not shown).
G455D mutation abrogates the PTS1-binding activity of YlPex5p
Full-length wild-type YlPex5p and Pex5p-G455D were tested for their ability to recognize variants of the PTS1 signal. The proteins were translated in itro and labelled with [$&S]methionine to facilitate the detection of any weak interactions. Wild-type YlPex5p was specifically retained on GST-SKL and GST-AKI beads (Figure 4, WT) . The C-terminal tripeptide AKI has been shown to function as a PTS1 in Candida albicans and Saccharomyces cere isiae [47] ; Y. lipolytica contains peroxisomal proteins that are immunoreactive with anti-AKI antiserum [48] . Domains of Y. lipolytica Pex5p YlPex5p was not retained either on GST-LKS beads, in which the C-terminal tripeptide does not conform to the PTS1 consensus, or on GST-SKLS beads, in which the canonical PTS1 is displaced from the extreme C-terminus by the addition of an extra amino acid, a construction that has been shown to prevent the targeting to peroxisomes of a protein normally resident in peroxisomes [49] . Therefore wild-type YlPex5p recognized only functional PTS1 tripeptides.
Figure 3 Growth of wild-type and pex5 mutant strains on oleate and acetate
Strains E122, pex5-1, pex5-KO and pex5-G455D were pregrown in YEPD medium. Cultures were adjusted to the same attenuance ; serial 2-fold dilutions were plated on YNO (containing oleate) or YNA (containing acetate). Growth was for 4 days (YNO) or 2 days (YNA) at 30 mC.
In contrast with the wild-type protein, Pex5p-G455D was not specifically retained on beads containing any of the PTS1 variants tested (Figure 4, G455D) , suggesting that the Gly Asp substitution prevented the mutant YlPex5p from binding to PTS1s. These results are in agreement with the previous finding that anti-SKL-reactive proteins associated with YlPex5p from wildtype cells but not with the mutant form of YlPex5p from pex5-1 cells [12] .
TPR domain of YlPex5p is necessary for its interaction with PTS1 but is not sufficient for functional complementation of a pex5 deletion mutant
To delineate the region(s) of YlPex5p involved in PTS1 recognition, truncated variants of YlPex5p were labelled with [$&S]methionine by translation in itro and assayed for their PTS1 binding activity. Deletions of regions N-terminal to the TPR domain did not significantly alter the specific PTS1 binding ability of truncated variants relative to that of wild-type YlPex5p ( Figure 5 ; compare B and C with WT). These results support the observation that, in the context of a fusion chimaera, the first 46 residues of YlPex5p were not required for interaction with a PTS1 (Figure 1 ). In contrast, deletion of the N-terminus and the first half of the TPR domain of YlPex5p resulted in a variant with no PTS1 binding activity ( Figure 5, E) . C-terminally truncated variants that terminated either just before the TPR domain ( Figure 5, A) or two residues into the fourth TPR motif ( Figure 5, D) failed to show PTS1 binding activity. Removal of the region C-terminal to the TPR domain significantly decreased, but did not completely eliminate, PTS1 binding ( Figure 5, F) . This low level of binding was reproducible. Taken together, these results suggest that the N-terminal 300 residues of YlPex5p were completely dispensable for PTS1 binding, the C-terminal tail (residues 550-598) of YlPex5p was not required for PTS1 recognition but does increase the efficacy of the binding reaction, and the TPR domain of YlPex5p was essential for binding PTS1. Therefore the minimum PTS1-binding domain of YlPex5p is predicted to lie within residues 301-549. Surprisingly, a protein with these endpoints (Figure 5 , CF) showed no PTS1 binding activity, even when present in a 4-fold molar excess over wildtype or mutant F proteins. However, a protein consisting of amino acids 155-549 of YlPex5p ( Figure 5 , BF) had a low level of PTS1 binding activity similar to that of mutant F, suggesting that the region between residues 155 and 300 also had a role in PTS1 recognition and\or in stabilization of the interaction between the targeting signal and its receptor.
Figure 4 Analysis of wild-type YlPex5p and Pex5p-G455D PTS1 binding activities
Wild-type Yl Pex5p (WT) and Pex5p-G455D (G455D) were labelled with [
35 S]methionine by transcription/translation in vitro. Equimolar amounts of the proteins were preincubated with buffer containing BSA at 10 µg/µl before incubation with immobilized GST proteins terminating with the amino acid sequence SKL, LKS, AKI or SKLS. After extensive washing, bound proteins were eluted by boiling in SDS/PAGE sample buffer and separated by SDS/PAGE. Shown is the fluorograph of the total amount of labelled protein eluted from the GST beads. The signal from an amount equivalent to 25 % of the total labelled protein used in the reaction is shown for reference (25 % input).
The biological activity of YlPex5p variants was assayed by testing their capacity for functional complementation of the growth defect of the pex5-KO disruption strain on oleate medium ( Figure 6 ). The PEX5 promoter was used to drive the expression of the various variant YlPex5p gene constructs. Although all transformants displayed strong growth on medium containing acetate as the carbon source ( Figure 6 , bottom panels), which does not require functional peroxisomes for its metabolism, only the transformant carrying a plasmid encoding the wild-type YlPex5p showed robust growth on oleate medium ( Figure 6 , middle panels), which does require functional peroxisomes for its metabolism. The strain synthesizing mutant F, lacking only the C-terminal end of YlPex5p, grew slowly on oleate medium. No growth on oleate medium was observed for strains synthesizing any of the other YlPex5p variants or for the strain carrying the empty vector alone. Cell lysates of the various transformants were analysed by immunoblotting to determine whether they were producing the different YlPex5p variants (Figure 6 , top panel). Appreciable quantities of YlPex5p variants were made in all cases, except for variant E, for which no signal was detected even after overexposure of the blot (results not shown). Variant E was probably unstable because a version of variant E with two copies of an influenza haemagglutinin epitope tag appended to its C-terminus could not be detected with the appropriate monoclonal antibody (results not shown). The reason for the absence of a signal for variant E was not investigated further. From the results of the growth assay ( Figure 6 ) and the PTS1 binding data in itro (Figure 5 ), it can be concluded that the ability to recognize a PTS1 is necessary but not sufficient to confer full biological activity on a YlPex5p variant.
DISCUSSION
Y. lipolytica and other yeast species have proved to be invaluable tools for the identification of components required for peroxisome assembly. The PEX5 gene of Y. lipolytica was identified in a genetic screen for mutants of peroxisome biogenesis [12] and shows high amino acid sequence similarity to genes from other organisms that encode PTS1 receptors [4, 6, [9] [10] [11] 14, 20] . Although the original mutant strain pex5-1 synthesizes a YlPex5p of normal size, unlike the wild-type YlPex5p, it is not found in association with anti-SKL-reactive proteins in i o [12] . Analysis of the pex5-1 allele revealed that the mutant strain produces a YlPex5p with an aspartic residue substituted for a conserved glycine residue at position 455 ( Figure 2 ). The G455D substitution did not support PTS1 binding by YlPex5p in an in itro assay ( Figure 4) ; together with the lack of detectable PTS1 interaction in i o [12] , this suggests a cause for the mutant pex5-1 phenotype. The results presented here are consistent with a model in which the pex5-1 mutant fails to assemble peroxisomes correctly because of the inability of the mutant YlPex5p to recognize the PTS1 motif rather than because of its inability to interact with other components of the peroxisomal protein import machinery. Although the latter possibility could exist, given that most wild-type YlPex5p is associated with the peroxisomal membrane and YlPex5p from pex5-1 cells is found exclusively in the peroxisomal matrix [12] , any loss of interaction between the
Figure 6 Growth characteristics of strains expressing wild-type and truncated forms of YlPex5p
Lanes are labelled to correspond with the constructs detailed in Figure 5 . Top panel : pex5-KO cells carrying plasmid pINA443 (443) or pINA443 with an insert encoding wild-type (WT) or a particular truncated form of YlPex5p (A to BF) were precultured for 16 h in glucose-containing 2iCMD medium and then transferred to oleic acid-containing 2iCMO for 6 h. Cell lysates were prepared by disruption with glass beads. Each lysate (30 µg) was separated by SDS/PAGE and subjected to immunoblotting with anti-Yl Pex5p serum. The panel is a composite of two images : lanes B to BF were exposed for six times longer than lanes 443 to F. The numbers at the left indicate the positions of molecular size standards (in kDa). Bottom panels : pex5-KO strains carrying the plasmids described above precultured in 2iCMD, adjusted to the same cell density and plated on 2iCMO (oleate) or YNA (acetate). Growth was at 30 mC for 4 days on 2iCMO or 2 days on YNA.
mutant YlPex5p and other components of the peroxisomal translocation machinery seems to be a secondary effect of the inability of the mutant YlPex5p to recognize a PTS1 because a purified YlPex5p fusion protein is capable of binding to an SKL tripeptide without the participation of any other factor ( Figure  1B) . TPR domains are predicted to form pairs of anti-parallel α-helices that interlock with the ' knobs ' of one helix (formed by bulky residues such as tyrosine or phenylalanine) fitting into the ' holes ' (formed by small amino acids such as glycine or alanine) of the adjacent helix [18, 50] . The fact that the mutated amino acid residue in the YlPex5p of pex5-1 cells is a conserved glycine implies that the structure of the TPR domain might be compromised in the mutant protein. Gly-455 is the eighth residue of the fifth TPR motif of YlPex5p. Not only is this residue conserved in Pex5p family members (Figure 2 ) but also, in general, a small amino acid is found in the eighth position of repeats of TPRcontaining proteins with diverse functions [18] . Recently, two inactivating mutations in Chinese hamster Pex5p were found to involve substitutions of glutamic residues for glycine residues at position 298 in the first TPR motif and at position 485 in the sixth TPR motif [15] .
Deletion analysis of YlPex5p was performed to define the regions needed for recognition of a PTS1. The N-terminal 300 residues of YlPex5p are not required for its association with a PTS1 because YlPex5p variants with deletions in this region showed approximately wild-type levels of PTS1 binding activity ( Figure 5 , WT, B and C). The TPR domain is essential for the interaction of YlPex5p with a PTS1 because every truncation tested in which part or all of the TPR domain was missing failed to show PTS1 binding activity ( Figure 5, A, D and E) . The Cterminal end (residues 550-598) of YlPex5p is not absolutely required for PTS1 recognition but its removal significantly decreases the PTS1 binding activity of YlPex5p ( Figure 5, F and BF) . Removal of the C-terminal end of YlPex5p also makes the region of residues 155-300 necessary for PTS1 binding because the TPR domain alone does not show PTS1 binding activity ( Figure 5 , CF). An intact TPR domain has been shown to be required for full PTS1 binding activity of S. cere isiae Pex5p (ScPex5p) [6] . There seem to be residues critical for PTS1 binding outside the TPR motifs of ScPex5p because deletion of the C-terminal 48 residues abolishes PTS1 binding, and a ScPex5p variant that initiates 6 residues before the TPR domain has only very weak PTS1 binding activity. In contrast, the first three TPR motifs of P. pastoris Pex5p (PpPex5p) are sufficient and necessary for binding a PTS1 in itro [20] . Truncation mutant D of YlPex5p ( Figure 5 ) was designed to mimic the C-terminal deletion in the minimal PTS1-binding domain of PpPex5p (i.e. termination after the second amino acid of the fourth TPR motif) but no interaction was detected between mutant D and GST-SKL. It therefore seems that, in terms of the structural requirements for PTS1 binding, YlPex5p is more similar to ScPex5p than it is to PpPex5p.
The role of YlPex5p in peroxisome biogenesis is greater than simply its ability to bind a PTS1 tripeptide, because the extent of PTS1 binding by a YlPex5p variant ( Figure 5 ) did not necessarily predict its ability to restore peroxisome function in a pex5 gene disruption strain ( Figure 6 ). Variants B and C (which lack the Nterminal 154 and 300 residues respectively of Pex5p) showed approximately wild-type levels of PTS1 binding activity but were unable to complement the pex5-KO strain for growth on oleic acid-containing medium. Mutant F, which lacks the C-terminal 48 residues of YlPex5p, showed weak PTS1 binding and was able to complement the pex5-KO strain partly. Mutant BF (residues 155-549) also bound GST-SKL weakly but did not complement the pex5-KO strain, reinforcing the functional importance of the N-terminal region of YlPex5p.
Why might a mutant YlPex5p that retains PTS1 binding ability not be fully biologically functional ? Several reasons can be put forward. (1) The deleted region of YlPex5p could include information required to direct it to peroxisomes. YlPex5p does not have a recognizable PTS ; the domain responsible for peroxisomal targeting has yet to be characterized. (2) The mutant YlPex5p might fail to interact with other components of the peroxisomal translocation machinery. Peroxin binding partners for YlPex5p await identification. (3) The mutant YlPex5p might not assume the correct quaternary protein structure. Purified human Pex5p produced in E. coli has recently been shown to exist as a homotetramer ; the domain responsible for oligomerization was located within the N-terminal 213 residues [40] . (4) Truncated forms of YlPex5p might lack one or more domains needed for the release of PTS1-bearing proteins in a timely fashion, resulting in prolonged lives for complexes of YlPex5p and cargo proteins and preventing YlPex5p from recycling to pick up new cargo. Experiments are currently under way to address these issues.
In conclusion, we have demonstrated that YlPex5p can bind specifically, directly and autonomously with functional PTS1 motifs. We also have shown that an intact TPR domain of YlPex5p is necessary but not sufficient for both interaction with a PTS1 and functional complementation of a strain lacking YlPex5p. 
